Lymphatica Medtech SA
PrivateLast Round
Series B
Oct 8, 2024
Total Funding Raised
$25.04M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lymphatica Medtech SA operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a Series B round in October 2024.
Lymphatica Medtech SA is a medical device company that develops implantable systems for the treatment of chronic lymphedema.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lymphatica Medtech SA Comparables
Compare Lymphatica Medtech SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sub-Q Bionics | 79% | |
| Fibralign Corporation | 77% | |
| Koya Medical | 66% |
For institutional investors. Book with your work email.
Lymphatica Medtech SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 8, 2024 | ||||
| Debt | Jun 15, 2023 | ||||
| Grant | Apr 28, 2023 | ||||
| Series A | Dec 3, 2020 | ||||
| Grant | Apr 1, 2019 | ||||
Accelerator | Dec 7, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lymphatica Medtech SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Foundation for Technological Innovation | Debt |
| EIT Health | Series A |
| Club degli Investitori | Series B |
| Panakès Partners | Series B |
| High-Tech Gründerfonds | Series B, Series A |
| Venture Kick | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 347% MoM, reaching 1.3K.
- Jul 16, 2026
Grew 25% QoQ, from 16 to 20 employees.
For institutional investors. Book with your work email.
Lymphatica Medtech SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lymphatica Medtech SA's valuation, stock price, and market status.
Is Lymphatica Medtech SA a public or private company?
Lymphatica Medtech SA is a private company.
What is the current stock price of Lymphatica Medtech SA?
Lymphatica Medtech SA is a private company, so its shares have no public market price. Caplight tracks Lymphatica Medtech SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lymphatica Medtech SA worth (valuation)?
Valuation information for Lymphatica Medtech SA is not publicly available.
Can I buy Lymphatica Medtech SA stock?
Lymphatica Medtech SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lymphatica Medtech SA's last funding round?
Lymphatica Medtech SA's most recent funding round was Series B on October 8, 2024.
Who are the main investors in Lymphatica Medtech SA?
Key investors in Lymphatica Medtech SA include Panakès Partners, High-Tech Gründerfonds, TechWald Holding.
Will Lymphatica Medtech SA IPO soon?
No public IPO plans have been announced for Lymphatica Medtech SA.
How can I track Lymphatica Medtech SA secondary market activity?
Caplight tracks bids, offers, and trades in Lymphatica Medtech SA's shares on secondary markets.